MedTrace Logo

Elastic Band Versus Free Weight Resistance Training in Phase 2 of CABG Patients.

NCT07331584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2026-01-12

No results posted yet for this study

Summary

The aim of this study compares the effects of elastic band and free weights on functional capacity, lung function and quality of life in phase 2 coronary artery bypass grafting patients. Resistance training is vital in cardiac rehabilitation for improving physical function, strength, and independence. These patients typically experience reduced functional capacity and lung function due to post-surgical deconditioning and inactivity, which can also impact quality of life.Determining whether elastic bands or free weights provide greater benefits in these areas may help optimize cardiac rehabilitation protocols by identifying a safe, effective, and accessible approach for improving patient outcomes. This research has the potential to guide evidence-based resistance training in post- coronary artery bypass grafting rehabilitation, ultimately supporting recovery and enhancing quality of life of patients.

Conditions

  • CABG

Interventions

OTHER

dumbell

Group A will receive the exercises from dumb bells we will focus on both upper limb and lower limb the total session would be of 20-30 minutes, will be focusing on chest (pectoralis major), back (latissimus dorsi, rhomboids), legs (quadriceps, hamstring, glutes) and core (abdominals, lower back) and after that 5-7 min of cool down. Dyspnea will be measured.

OTHER

thera band

Group B will receive the exercise form elastic band (TheraBand) for both upper limb and lower limb. Total session time would be 30 minutes will be focusing on chest (pectoralis major), back (latissimus dorsi, rhomboids), legs (quadriceps, hamstring, glutes) and core (abdominals, lower back) 10-12 reps and 1 set in starting progressively increased to 3 reps after that at the end of session 5-7 min cool down and gentle stretching 2 times per week for 12 weeks. Dyspnea should be monitored.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Riffat Malik · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-17
Primary Completion
2025-12-17
Completion
2025-12-17

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07331584 on ClinicalTrials.gov